Adjuvant administration modulates the process of beta-cell autoimmunity and prevents IDDM: introduction to human trials.
Vardi
P
P
National Center for Childhood Diabetes, Children's Medical Center of Israel, Petah-Tikva.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D015551:Autoimmunity; D001500:BCG Vaccine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology; D003921:Diabetes Mellitus, Experimental / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D005260:Female; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology; D008297:Male
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D016207:Cytokines